A brilliant disguise for self RNA: 5′-End and internal modifications of primary transcripts suppress elements of innate immunity

RNA Biology

Volumn 5, Issue 3, 2008, Pages

  Nallagatla, Subba Rao ^a   Toroney, Rebecca ^a   Bevilacqua, Philip C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Modified RNA; PKR; RNA structure; Self and non self RNA; Translation inhibition

Indexed keywords

BACTERIAL RNA; DOUBLE STRANDED RNA; NUCLEOSIDE; PHOSPHATE; PROTEIN KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; VIRUS RNA;

CARCINOGENESIS; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME REPRESSION; HUMAN; INNATE IMMUNITY; NONHUMAN; REVIEW; RNA METHYLATION; RNA STRUCTURE; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS);

EID: 85011936098     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.5.3.6839     Document Type: Review

References (46)

1. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998; 67:227-64.
2. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809.
3. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007; 6:975-90.
4. Thompson AJ, Locarnini SA. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol 2007; 85:435-45.
5. Kariko K, Weissman D. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. Curr Opin Drug Discov Devel 2007; 10:523-32.
6. Chi H, Flavell RA. Innate recognition of non-self nucleic acids. Genome Biol 2008; 9:211.
7. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89:1-47.
8. Bowie AG, Fitzgerald KA. RIG-I: tri-ing to discriminate between self and non-self RNA. Trends Immunol 2007; 28:147-50.
9. Saito T, Gale M, Jr. Principles of intracellular viral recognition. Curr Opin Immunol 2007; 19:17-23.
10. Lamphier MS, Sirois CM, Verma A, Golenbock DT, Latz E. TLR9 and the recognition of self and non-self nucleic acids. Ann N Y Acad Sci 2006; 1082:31-43.
11. Schlee M, Hornung V, Hartmann G. siRNA and isRNA: two edges of one sword. Mol Ther 2006; 14:463-70.
12. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that cooperate in innate immunity. Trends Immunol 2006; 27:352-7.
13. Sioud M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 2006; 12:167-76.
14. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7:131-7.
15. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
16. Manche L, Green SR, Schmedt C, Mathews MB. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 1992; 12:5238-48.
17. Williams BR. PKR; a sentinel kinase for cellular stress. Oncogene 1999; 18:6112-20.
18. Nallagatla SR, Hwang J, Toroney R, Zheng X, Cameron CE, Bevilacqua PC. 5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 2007; 318:1455-8.
19. Nallagatla SR, Bevilacqua PC. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA 2008; 14:1201-13.
20. Sadler AJ, Williams BR. Structure and function of the protein kinase R. Curr Top Microbiol Immunol 2007; 316:253-92.
21. Farrell PJ, Sen GC, Dubois MF, Ratner L, Slattery E, Lengyel P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A 1978; 75:5893-7.
22. Hovanessian AG. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2′-5′oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev 2007; 18:351-61.
23. Zheng X, Bevilacqua PC. Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA 2004; 10:1934-45.
24. Schlee M, Barchet W, Hornung V, Hartmann G. Beyond double-stranded RNA-type I IFN induction by 3pRNA and other viral nucleic acids. Curr Top Microbiol Immunol 2007; 316:207-30.
25. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. RIG-Imediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006; 314:997-1001.
26. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314:994-7.
27. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730-7.
28. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006; 103:8459-64.
29. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101-5.
30. Johnson LN, Noble ME, Owen DJ. Active and inactive protein kinases: structural basis for regulation. Cell 1996; 85:149-58.
31. Berg JM, Tymoczko JL, Stryer L. Biochemistry. New York: W. H. Freeman and Company, 2007.
32. Grosjean H. Modification and editing of RNA: historical overview and important facts to remember. Topics in Current Genetics: Fine Tuning of RNA Functions by Modifications and Editing. Berlin Heidelberg: Springer-Verlag, 2005: 12:1-22.
33. Rozenski J, Crain PF, McCloskey JA. The RNA Modification Database: 1999 update. Nucleic Acids Res 1999; 27:196-7.
34. Ryter JM, Schultz SC. Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. EMBO J 1998; 17:7505-13.
35. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 2007; 8:763-9.
36. Weeks KM, Crothers DM. Major groove accessibility of RNA. Science 1993; 261:1574-7.
37. Varani G, McClain WH. The G x U wobble base pair. A fundamental building block of RNA structure crucial to RNA function in diverse biological systems. EMBO Rep 2000; 1:18-23.
38. Hall KB. RNA-protein interactions. Curr Opin Struct Biol 2002; 12:283-8.
39. Tian B, Bevilacqua PC, Diegelman-Parente A, Mathews MB. The double-stranded-RNA-binding motif: interference and much more. Nat Rev Mol Cell Biol 2004; 5:1013-23.
40. Le Hir H, Gatfield D, Izaurralde E, Moore MJ. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J 2001; 20:4987-97.
41. Jeffrey IW, Kadereit S, Meurs EF, Metzger T, Bachmann M, Schwemmle M, Hovanessian AG, Clemens MJ. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res 1995; 218:17-27.
42. Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005; 23:165-75.
43. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5:1052-60.
44. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8:49-62.
45. Judge AD, Bola G, Lee AC, MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 2006; 13:494-505.
46. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11:263-70.